New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Go back to New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
CARLISLE COMPANIES, Inc. (NYSE: CSL) Delayed: 341.48 -10.66 (3.03%)
Previous Close $352.14    52 Week High $114.49 
Open $350.60    52 Week Low $75.17 
Day High $353.65    P/E 94.59 
Day Low $340.79    EPS $3.61 
Volume 361,889       

(AMEX: CSLLY) Delayed: 31.55 -0.06 (0.19%)
Previous Close $31.61    52 Week High $45.60 
Open $31.66    52 Week Low $33.39 
Day High $31.67    P/E N/A 
Day Low $30.23    EPS $0.00 
Volume 92,282